{
  "id": "625ebd06e764a53204000031",
  "type": "list",
  "question": "What are the diagnostic criteria for hemophagocytic lymphohistiocytosis?",
  "ideal_answer": "Hemophagocytic syndrome (HS) is a severe hyper inflammatory condition whose cardinal symptoms are prolonged fever, cytopenia, hepatosplenomegaly, and hemophagocytosis by activated, morphologically benign macrophages.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/32300936",
    "http://www.ncbi.nlm.nih.gov/pubmed/16937360",
    "http://www.ncbi.nlm.nih.gov/pubmed/34850652",
    "http://www.ncbi.nlm.nih.gov/pubmed/24583560",
    "http://www.ncbi.nlm.nih.gov/pubmed/26512263",
    "http://www.ncbi.nlm.nih.gov/pubmed/30086677",
    "http://www.ncbi.nlm.nih.gov/pubmed/33658450",
    "http://www.ncbi.nlm.nih.gov/pubmed/32588191",
    "http://www.ncbi.nlm.nih.gov/pubmed/1561489",
    "http://www.ncbi.nlm.nih.gov/pubmed/21773661"
  ],
  "snippets": [
    {
      "text": "Hemophagocytic lymphohistiocytosis (HLH) is a rare and aggressive syndrome of excessive cytokine requiring prompt recognition and aggressive therapy.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32300936",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hemophagocytic lymphohistiocytosis (HLH) is a rare and life-threatening condition that is characterized by an overactive response of the immune system with excessive production of proinflammatory cytokines. Initial presentation of this condition often mimics and overlaps with many diseases including infections, sepsis, and multiorgan failure syndrome, which makes diagnosis the diagnosis of HLH challenging",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/34850652",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hemophagocytic syndrome (HPS) or hemophagocytic lymphohistiocytosis (HLH) is an acute and rapidly progressive systemic inflammatory disorder characterized by cytopenia, excessive cytokine production, and hyperferritinemia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/32588191",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hemophagocytic syndrome (HS) is a severe hyper inflammatory condition whose cardinal symptoms are prolonged fever, cytopenia, hepatosplenomegaly, and hemophagocytosis by activated, morphologically benign macrophages. ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/21773661",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Acquired hemophagocytic lymphohistiocytosis comprises a heterogenous group of hyperinflammatory immunoreactions often resulting in uncontrolled immune responses, mainly throughout proliferation of cytotoxic T cells and hemophagocytosis by macrophages.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/30086677",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": " and symptoms fulfilled the five criteria for a diagnosis of hemophagocytic lymphohistiocytosis, including fever, cytopenia, hemophagocytosis, hyperferritinemia, and high soluble interleukin-2 receptor levels. Therefore, the d",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/33658450",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "ostic criteria of hemophagocytic lymphohistiocytosis are the following: fever, splenomegaly, cytopenias affecting at least two of the 3 lineages in peripheral blood, hypertriglyceridemia and hyperferritinemia, elevated serum level of soluble interleukin-2 receptor (sCD25), hypofibrinogenemia, hemophagocytosis in bone marrow and decreased cytotoxic T cell and natural killer cell activity. In this cas",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24583560",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In HLH-94, the first prospective international treatment study for hemophagocytic lymphohistiocytosis (HLH), diagnosis was based on five criteria (fever, splenomegaly, bicytopenia, hypertriglyceridemia and/or hypofibrinogenemia, and hemophagocytosis). In HL",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16937360",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diagnostic criteria include idiopathic fever, splenomegaly, cytopenias, hypertriglyceridemia, hypofibrinogenemia, and the presence of hemophagocytosis",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1561489",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Hemophagocytic lymphohistiocytosis (HLH) is characterized by fever, splenomegaly, jaundice, and pathologic findings of hemophagocytosis in bone marrow or other tissues such as the lymph nodes and liver",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/26512263",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diagnostic criteria of hemophagocytic lymphohistiocytosis are the following: fever, splenomegaly, cytopenias affecting at least two of the 3 lineages in peripheral blood, hypertriglyceridemia and hyperferritinemia, elevated serum level of soluble interleukin-2 receptor (sCD25), hypofibrinogenemia, hemophagocytosis in bone marrow and decreased cytotoxic T cell and natural killer cell activity.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/24583560",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Diagnostic criteria include idiopathic fever, splenomegaly, cytopenias, hypertriglyceridemia, hypofibrinogenemia, and the presence of hemophagocytosis.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/1561489",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "In HLH-94, the first prospective international treatment study for hemophagocytic lymphohistiocytosis (HLH), diagnosis was based on five criteria (fever, splenomegaly, bicytopenia, hypertriglyceridemia and/or hypofibrinogenemia, and hemophagocytosis).",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/16937360",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "fever, splenomegaly, bicytopenia, hypertriglyceridemia, hypofibrinogenemia, hemophagocytosis, hyperferritinemia, excessive cytokine production, hepatosplenomegaly, Hemophagocytic lymphohistiocytosis is a rare and aggressive syndrome of excessive cytokine requiring prompt recognition and aggressive therapy."
}